PP
AGN

Paloma Partners’s Allergan plc AGN Stock Holding History

Paloma Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-12,600
Closed -$1.84M – 2347
2019
Q1 		$1.84M Sell
12,600
-13,700
-52% -$1.99M 0.04% 486
2018
Q4 		$31K Buy
+26,300
New +$4.31M ﹤0.01% 1180
2018
Q3 		– Hold
0
– – – 189
2018
Q2 		– Sell
-14,700
Closed -$2.47M – 2402
2018
Q1 		$2.47M Buy
+14,700
New +$2.47M 0.04% 463
2017
Q4 		– Sell
-7,600
Closed -$1.56M – 2451
2017
Q3 		$1.56M Sell
7,600
-17,600
-70% -$4.09M 0.02% 896
2017
Q2 		$6.13M Buy
+25,200
New +$5.92M 0.07% 265
2016
Q4 		– Sell
-36,000
Closed -$8.29M – 2229
2016
Q3 		$8.29M Hold
36,000
– – 0.1% 117
2016
Q2 		$8.32M Buy
+36,000
New +$8.3M 0.09% 128
2015
Q4 		– Sell
-4,000
Closed -$1.09M – 2009
2015
Q3 		$1.09M Buy
+4,000
New +$1.23M 0.03% 608

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Paloma Partners's AGN Position: Q2 2020 in Review

Paloma Partners sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 59,966 shares — an estimated $10.6M sold.

Paloma Partners first reported a position in AGN in Q3 2013 and held it in 21 quarters. The position peaked at $30.1M in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Paloma Partners reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Paloma Partners sold 59,966 Allergan plc shares in Q2 2020, an estimated $10.6M.
  • Paloma Partners first reported a position in Allergan plc in Q3 2013 and held it in 21 quarters.
  • Paloma Partners's Allergan plc position peaked at $30.1M in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Paloma Partners's 13F filing for Q2 2020, filed 14 Aug 2020.